Ultrasound contrast agent for clearer heart images
Part of Heart & circulation clinical trials.
This trial tests a new contrast agent called NH002 that is given through an IV to help doctors see the heart more clearly during an ultrasound (echocardiogram). It may help people whose standard heart ultrasound did not provide clear images of the heart's left ventricle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have or be suspected of having heart disease
- Had a heart ultrasound in the last 30 days that did not clearly show the left ventricle (the heart's main pumping chamber)
- Not have severe heart or lung conditions, such as recent heart attack, uncontrolled heart rhythm problems, severe heart failure, or very high or low blood pressure
- Not be allergic to the study drug, other ultrasound contrast agents (like Definity), or products containing PEG (like some laxatives)
- Not be pregnant, planning to become pregnant, or breastfeeding, and use reliable birth control if able to have children
- Not have taken any experimental drugs in the last 30 days, and not have had any contrast agent (oral or IV) in the last 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
This trial compares two ways of giving Lumason (an ultrasound contrast agent) to improve images of the left ventricle in people whose initial heart ultrasound was unclear. It may help those with a 'suboptimal' view of the heart's pumping chamber.
This trial tests an automated computer tool that helps guide an ultrasound exam of the heart, aiming to get better, usable images. You may benefit if your heart ultrasound is usually hard to capture or takes extra effort to obtain clear pictures.
This study tests whether using a small ultrasound device at the patient's bedside (point-of-care ultrasound) can help doctors better manage fluid buildup in people with chronic heart failure. The goal is to see if this extra imaging helps guide treatment and improve outcomes.
This study tests a new medicine called NT-88, which may help improve heart function in people with mild heart failure. It focuses on those with a slightly reduced pumping ability (LVEF 41-49%) and aims to see if the drug is safe and helpful.
This trial studies whether a newer, faster ultrasound imaging method can better assess areas of the heart that may not get enough blood during stress. You may be eligible if you have known coronary artery disease or are considered low risk, and if you can safely undergo the stress ultrasound test.
Hear when a new Cardiac Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.